Tom Hale
Showing 1–3 of 3 transcripts.
- Milken Institute59 min
Breakthroughs Reshaping Aging and Longevity | Global Conference 2026
Richard Lui, Joe Betts-LaCroix, Tom Hale, Richard Isaacson, Carina Kern, John Whyte
Leaders from Retro Biosciences, Aura Health, Link Jevity, and the AMA convened to discuss accelerating longevity medicine through therapies targeting necrosis and autophagy alongside continuous health monitoring. The panel identified critical systemic barriers including outdated reimbursement models and fragmented disease silos while highlighting breakthroughs like generative AI-driven drug discovery and home-based neuro-insight testing. With a predicted market readiness of 3 to 6 out of 10, the group anticipates the first anti-aging therapeutics will reach consumers within five years as the industry shifts from reactive sick care to proactive aging reversal.
- Sequoia Capital1h 0m
Oura’s Tom Hale: What People Don’t Tell You About Being CEO
Aura CEO Tom Hale navigates the "messy middle" of scaling 200 to 2,000 employees by rejecting bureaucratic layers and enforcing a hybrid work culture that balances American capitalism with Finnish social traditions. His controversial pivot from hardware sales to a $6 monthly subscription generated industry-leading retention by prioritizing continuous value delivery while strategically leveraging partnerships with Gucci to reposition the ring as a fashion accessory. Hale emphasizes that effective leadership requires operating across all functions to build empathy, maintaining a 90/10 missionary-to-mercenary ratio, and shielding the organization from the "Dilbert effect" by promoting internal candidates with a path to the C-suite.
- Milken Institute1h 0m
Accelerating a Healthier Future Through AI | Global Conference 2025
Gina Carithers, Jesse Ehrenfeld, Tom Hale, Kate Sasser, Johnese Spisso
A panel of experts from the AMA, UCLA Health, Tempus AI, and Aura discusses how artificial intelligence is accelerating the adoption of tools like ambient scribes and genomic analysis to address critical primary care shortages and administrative burdens. These leaders detail successful implementations at scale, noting that while automated workflows and continuous patient monitoring are improving clinical accuracy and reducing provider burnout, significant hurdles remain regarding interoperability and fragmented prior authorization systems. Looking forward, the group envisions a regulatory landscape that scales with risk, enabling AI to support personalized, data-driven care models that include digital twins and citizen science while maintaining strict safety protocols for high-stakes medical decisions.